{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Gene expression analysis", "Metabolic disorders", "Target identification"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "31098406", "DateCompleted": {"Year": "2020", "Month": "04", "Day": "20"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "05", "Day": "08"}], "Language": ["eng"], "ELocationID": ["173", "10.1038/s42003-019-0396-4"], "Journal": {"ISSN": "2399-3642", "JournalIssue": {"Volume": "2", "PubDate": {"Year": "2019"}}, "Title": "Communications biology", "ISOAbbreviation": "Commun Biol"}, "ArticleTitle": "Caffeine-free hawk tea lowers cholesterol by reducing free cholesterol uptake and the production of very-low-density lipoprotein.", "Pagination": {"StartPage": "173", "MedlinePgn": "173"}, "Abstract": {"AbstractText": ["Medicinal plants show important therapeutic value in chronic disease treatment. However, due to their diverse ingredients and complex biological effects, the molecular mechanisms of medicinal plants are yet to be explored. By means of several high-throughput platforms, here we show hawk tea extract (HTE) inhibits Niemann-Pick C1-like 1 (NPC1L1)-mediated free cholesterol uptake, thereby inducing the transcription of low-density lipoprotein receptor (<i>LDLR</i>) downstream of the sterol response element binding protein 2 (SREBP2) pathway. Meanwhile, HTE suppresses hepatocyte nuclear factor 4\u03b1 (HNF4\u03b1)-mediated transcription of microsomal triglyceride transfer protein (<i>MTP</i>) and apolipoprotein B (<i>APOB</i>), thereby decreasing the production of very-low-density lipoprotein. The catechin EGCG ((-)-epigallocatechin gallate) and the flavonoids kaempferol and quercetin are identified as the bioactive components responsible for the effects on the NPC1L1-SREBP2-LDLR axis and HNF4\u03b1-MTP/APOB axis, respectively. Overall, hawk tea works as a previously unrecognized cholesterol-lowering agent in a multi-target and multi-component manner."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1State Key Laboratory of Membrane Biology, School of Medicine, Tsinghua University, 100084 Beijing, China."}, {"Identifier": [], "Affiliation": "2Medical Systems Biology Research Center, School of Medicine, Tsinghua University, 100084 Beijing, China."}, {"Identifier": [], "Affiliation": "National Engineering Research Center for Beijing Biochip Technology, 102206 Beijing, China."}], "LastName": "Feng", "ForeName": "Juan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "4State Key Laboratory Breeding Base of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, 100700 Beijing, China."}], "LastName": "Yang", "ForeName": "Jian", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Research Center for Beijing Biochip Technology, 102206 Beijing, China."}], "LastName": "Chang", "ForeName": "Yujun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1State Key Laboratory of Membrane Biology, School of Medicine, Tsinghua University, 100084 Beijing, China."}, {"Identifier": [], "Affiliation": "2Medical Systems Biology Research Center, School of Medicine, Tsinghua University, 100084 Beijing, China."}, {"Identifier": [], "Affiliation": "National Engineering Research Center for Beijing Biochip Technology, 102206 Beijing, China."}], "LastName": "Qiao", "ForeName": "Liansheng", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Research Center for Beijing Biochip Technology, 102206 Beijing, China."}], "LastName": "Dang", "ForeName": "Honglei", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1State Key Laboratory of Membrane Biology, School of Medicine, Tsinghua University, 100084 Beijing, China."}, {"Identifier": [], "Affiliation": "2Medical Systems Biology Research Center, School of Medicine, Tsinghua University, 100084 Beijing, China."}, {"Identifier": [], "Affiliation": "National Engineering Research Center for Beijing Biochip Technology, 102206 Beijing, China."}], "LastName": "Luo", "ForeName": "Kun", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Research Center for Beijing Biochip Technology, 102206 Beijing, China."}], "LastName": "Guo", "ForeName": "Hongyan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Research Center for Beijing Biochip Technology, 102206 Beijing, China."}], "LastName": "An", "ForeName": "Yannan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Research Center for Beijing Biochip Technology, 102206 Beijing, China."}], "LastName": "Ma", "ForeName": "Chengmei", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Research Center for Beijing Biochip Technology, 102206 Beijing, China."}], "LastName": "Shao", "ForeName": "Hong", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Engineering Research Center for Beijing Biochip Technology, 102206 Beijing, China."}], "LastName": "Tian", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "4State Key Laboratory Breeding Base of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, 100700 Beijing, China."}], "LastName": "Yuan", "ForeName": "Yuan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1State Key Laboratory of Membrane Biology, School of Medicine, Tsinghua University, 100084 Beijing, China."}, {"Identifier": [], "Affiliation": "2Medical Systems Biology Research Center, School of Medicine, Tsinghua University, 100084 Beijing, China."}, {"Identifier": [], "Affiliation": "National Engineering Research Center for Beijing Biochip Technology, 102206 Beijing, China."}], "LastName": "Xie", "ForeName": "Lan", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1State Key Laboratory of Membrane Biology, School of Medicine, Tsinghua University, 100084 Beijing, China."}, {"Identifier": [], "Affiliation": "2Medical Systems Biology Research Center, School of Medicine, Tsinghua University, 100084 Beijing, China."}, {"Identifier": [], "Affiliation": "National Engineering Research Center for Beijing Biochip Technology, 102206 Beijing, China."}], "LastName": "Xing", "ForeName": "Wanli", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1State Key Laboratory of Membrane Biology, School of Medicine, Tsinghua University, 100084 Beijing, China."}, {"Identifier": [], "Affiliation": "2Medical Systems Biology Research Center, School of Medicine, Tsinghua University, 100084 Beijing, China."}, {"Identifier": [], "Affiliation": "National Engineering Research Center for Beijing Biochip Technology, 102206 Beijing, China."}], "LastName": "Cheng", "ForeName": "Jing", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Commun Biol", "NlmUniqueID": "101719179", "ISSNLinking": "2399-3642"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticholesteremic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Kaempferols"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipoproteins, VLDL"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, LDL"}, {"RegistryNumber": "0", "NameOfSubstance": "Sterol Regulatory Element Binding Protein 2"}, {"RegistryNumber": "3G6A5W338E", "NameOfSubstance": "Caffeine"}, {"RegistryNumber": "731P2LE49E", "NameOfSubstance": "kaempferol"}, {"RegistryNumber": "8R1V1STN48", "NameOfSubstance": "Catechin"}, {"RegistryNumber": "97C5T2UQ7J", "NameOfSubstance": "Cholesterol"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}, {"RegistryNumber": "BQM438CTEL", "NameOfSubstance": "epigallocatechin gallate"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Anticholesteremic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Biological Transport, Active"}, {"QualifierName": ["analysis"], "DescriptorName": "Caffeine"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Catechin"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cholesterol"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Dyslipidemias"}, {"QualifierName": [], "DescriptorName": "Feeder Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gastrointestinal Microbiome"}, {"QualifierName": [], "DescriptorName": "Hep G2 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Kaempferols"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Lipid Metabolism"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Lipoproteins, VLDL"}, {"QualifierName": ["chemistry"], "DescriptorName": "Litsea"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Liver"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Models, Biological"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Quercetin"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["genetics"], "DescriptorName": "Receptors, LDL"}, {"QualifierName": ["metabolism"], "DescriptorName": "Sterol Regulatory Element Binding Protein 2"}, {"QualifierName": ["analysis"], "DescriptorName": "Teas, Medicinal"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ferranti SD, Neufeld E, Walker WA, Watkins JB, Duggan C. Hyperlipidemia and cardiovascular disease. Curr. Opin. Lipidol. 2007;17:702\u2013704.", "ArticleIdList": ["17095916"]}, {"Citation": "Collaborators., G.M.A.C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117\u2013171. doi: 10.1016/S0140-6736(14)61682-2.", "ArticleIdList": ["10.1016/S0140-6736(14)61682-2", "PMC4340604", "25530442"]}, {"Citation": "Grundy SM. Statin trials and goals of cholesterol-lowering therapy. Circulation. 1998;97:1436\u20131439. doi: 10.1161/01.CIR.97.15.1436.", "ArticleIdList": ["10.1161/01.CIR.97.15.1436", "9576422"]}, {"Citation": "Davis HR, Veltri EP. Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia. J. Atheroscler. Thromb. 2007;14:99\u2013108. doi: 10.5551/jat.14.99.", "ArticleIdList": ["10.5551/jat.14.99", "17587760"]}, {"Citation": "Lin XL, Xiao LL, Tang ZH, Jiang ZS, Liu MH. Role of PCSK9 in lipid metabolism and atherosclerosis. Biomed. Pharmacother. 2018;104:36\u201344. doi: 10.1016/j.biopha.2018.05.024.", "ArticleIdList": ["10.1016/j.biopha.2018.05.024", "29758414"]}, {"Citation": "Cuchel M, et al. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study. Lancet. 2013;381:40\u201346. doi: 10.1016/S0140-6736(12)61731-0.", "ArticleIdList": ["10.1016/S0140-6736(12)61731-0", "PMC4587657", "23122768"]}, {"Citation": "Raal FJ, et al. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;375:998\u20131006. doi: 10.1016/S0140-6736(10)60284-X.", "ArticleIdList": ["10.1016/S0140-6736(10)60284-X", "20227758"]}, {"Citation": "Rader DJ. New therapeutic approaches to the treatment of dyslipidemia. Cell Metab. 2016;23:405\u2013412. doi: 10.1016/j.cmet.2016.01.005.", "ArticleIdList": ["10.1016/j.cmet.2016.01.005", "26853751"]}, {"Citation": "Pan SY, et al. New perspectives on how to discover drugs from herbal medicines: CAM\u2019s outstanding contribution to modern therapeutics. Evid. Based Complement. Alternat. Med. 2013;2013:627375.", "ArticleIdList": ["PMC3619623", "23634172"]}, {"Citation": "Bursill CA, Abbey M, Roach PD. A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis. 2007;193:86\u201393. doi: 10.1016/j.atherosclerosis.2006.08.033.", "ArticleIdList": ["10.1016/j.atherosclerosis.2006.08.033", "16970948"]}, {"Citation": "Hindmarch I, et al. A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology (Berl) 2000;149:203\u2013216. doi: 10.1007/s002130000383.", "ArticleIdList": ["10.1007/s002130000383", "10823400"]}, {"Citation": "Long P, et al. Commercialized non-Camellia tea: traditional function and molecular identification. Acta Pharm. Sin. B. 2014;4:227\u2013237. doi: 10.1016/j.apsb.2014.02.006.", "ArticleIdList": ["10.1016/j.apsb.2014.02.006", "PMC4629065", "26579387"]}, {"Citation": "Ye H, Yu J. The preliminary studies on antioxidation of three kinds of flavonoids from Litsea coreana. J. Chin. Med. Mater. 2004;27:113\u2013115.", "ArticleIdList": ["22454999"]}, {"Citation": "Jia X, Li P, Wan J, He C. A review on phytochemical and pharmacological properties of Litsea coreana. Pharm. Biol. 2017;55:1368\u20131374. doi: 10.1080/13880209.2017.1302482.", "ArticleIdList": ["10.1080/13880209.2017.1302482", "PMC7011990", "28301985"]}, {"Citation": "de la Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V. Metformin is associated with higher relative abundance of mucin degrading Akkermansia muciniphila and several short chain fatty acid-producing microbiota in the gut. Diabetes Care. 2017;1:54\u201362. doi: 10.2337/dc16-1324.", "ArticleIdList": ["10.2337/dc16-1324", "27999002"]}, {"Citation": "He K, et al. Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways. Biochim. Biophys. Acta. 2016;1862:1696\u20131709. doi: 10.1016/j.bbadis.2016.06.006.", "ArticleIdList": ["10.1016/j.bbadis.2016.06.006", "27287254"]}, {"Citation": "Raza GS, et al. Polydextrose changes the gut microbiome and attenuates fasting triglyceride and cholesterol levels in Western diet fed mice. Sci. Rep. 2017;7:5294\u20135304. doi: 10.1038/s41598-017-05259-3.", "ArticleIdList": ["10.1038/s41598-017-05259-3", "PMC5509720", "28706193"]}, {"Citation": "Chang C, et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat. Commun. 2015;6:7489\u20137505. doi: 10.1038/ncomms8489.", "ArticleIdList": ["10.1038/ncomms8489", "PMC4557287", "26102296"]}, {"Citation": "Yang SP, Wilson K, Kawa A, Raner GM. Effects of green tea extracts on gene expression in HepG2 and Cal-27 cells. Food Chem. Toxicol. 2006;44:1075\u20131081. doi: 10.1016/j.fct.2006.01.001.", "ArticleIdList": ["10.1016/j.fct.2006.01.001", "16487642"]}, {"Citation": "Singh DK, Banerjee S, Porter TD. Green and black tea extracts inhibit HMG-CoA reductase and activate AMP kinase to decrease cholesterol synthesis in hepatoma cells. J. Nutr. Biochem. 2009;20:816\u2013822. doi: 10.1016/j.jnutbio.2008.07.011.", "ArticleIdList": ["10.1016/j.jnutbio.2008.07.011", "PMC2758626", "18926682"]}, {"Citation": "Xie J, et al. Pu-erh tea water extract mediates cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Front. Pharmacol. 2017;8:190.", "ArticleIdList": ["PMC5382226", "28428754"]}, {"Citation": "Lv C, et al. The gene expression profiles in response to 102 traditional Chinese medicine (TCM) components: a general template for research on TCMs. Sci. Rep. 2017;7:352. doi: 10.1038/s41598-017-00535-8.", "ArticleIdList": ["10.1038/s41598-017-00535-8", "PMC5428649", "28336967"]}, {"Citation": "Brown MS, Goldstein J. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;4746:34\u201347. doi: 10.1126/science.3513311.", "ArticleIdList": ["10.1126/science.3513311", "3513311"]}, {"Citation": "Kong W, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 2004;10:1344\u20131351. doi: 10.1038/nm1135.", "ArticleIdList": ["10.1038/nm1135", "15531889"]}, {"Citation": "Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 2002;109:1125\u20131131. doi: 10.1172/JCI0215593.", "ArticleIdList": ["10.1172/JCI0215593", "PMC150968", "11994399"]}, {"Citation": "Adams CM, et al. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J. Biol. Chem. 2004;279:52772\u201352780. doi: 10.1074/jbc.M410302200.", "ArticleIdList": ["10.1074/jbc.M410302200", "15452130"]}, {"Citation": "Miettinen TA, Gylling H. Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment. Eur. J. Clin. Invest. 2003;33:976\u2013982. doi: 10.1046/j.1365-2362.2003.01229.x.", "ArticleIdList": ["10.1046/j.1365-2362.2003.01229.x", "14636301"]}, {"Citation": "Yu L, et al. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J. Biol. Chem. 2006;281:6616\u20136624. doi: 10.1074/jbc.M511123200.", "ArticleIdList": ["10.1074/jbc.M511123200", "16407187"]}, {"Citation": "Wang LJ, Song BL. Niemann-Pick C1-Like 1 and cholesterol uptake. Biochim. Biophys. Acta. 2012;1821:964\u2013972. doi: 10.1016/j.bbalip.2012.03.004.", "ArticleIdList": ["10.1016/j.bbalip.2012.03.004", "22480541"]}, {"Citation": "Ge L, et al. The cholesterol absorption inhibitor Ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab. 2008;7:508\u2013519. doi: 10.1016/j.cmet.2008.04.001.", "ArticleIdList": ["10.1016/j.cmet.2008.04.001", "18522832"]}, {"Citation": "Repa JJ, Turley SD, Quan G, Dietschy JM. Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption. J. Lipid Res. 2005;46:779\u2013789. doi: 10.1194/jlr.M400475-JLR200.", "ArticleIdList": ["10.1194/jlr.M400475-JLR200", "15654122"]}, {"Citation": "Liu Y, Manchekar M, Sun Z, Richardson PE, Dashti N. Apolipoprotein B-containing lipoprotein assembly in microsomal triglyceride transfer protein-deficient McA-RH7777 cells. J. Lipid Res. 2010;51:2253\u20132264. doi: 10.1194/jlr.M005371.", "ArticleIdList": ["10.1194/jlr.M005371", "PMC2903790", "20181985"]}, {"Citation": "Dixon JL, Ginsberg HN. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J. Lipid Res. 1993;34:167\u2013179.", "ArticleIdList": ["8381452"]}, {"Citation": "Sato R, et al. Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription. J. Biol. Chem. 1999;274:24714\u201324720. doi: 10.1074/jbc.274.35.24714.", "ArticleIdList": ["10.1074/jbc.274.35.24714", "10455139"]}, {"Citation": "Sheena V, et al. Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4. J. Lipid Res. 2004;46:328\u2013341. doi: 10.1194/jlr.M400371-JLR200.", "ArticleIdList": ["10.1194/jlr.M400371-JLR200", "15547294"]}, {"Citation": "Kel AE, Niehof M, Matys V, Zemlin R, Borlak J. Genome wide prediction of HNF4alpha functional binding sites by the use of local and global sequence context. Genome Biol. 2008;9:1\u201319. doi: 10.1186/gb-2008-9-2-r36.", "ArticleIdList": ["10.1186/gb-2008-9-2-r36", "PMC2374721", "18291023"]}, {"Citation": "Ye JH, et al. Preparation of partially decaffeinated instant green tea. J. Agric. Food Chem. 2007;55:3498\u20133502. doi: 10.1021/jf070046c.", "ArticleIdList": ["10.1021/jf070046c", "17407319"]}, {"Citation": "Kiselyuk A, et al. HNF4alpha antagonists discovered by a high-throughput screen for modulators of the human insulin promoter. Chem. Biol. 2012;19:806\u2013818. doi: 10.1016/j.chembiol.2012.05.014.", "ArticleIdList": ["10.1016/j.chembiol.2012.05.014", "PMC3447631", "22840769"]}, {"Citation": "Bennett AJ, Billett MA, Salter AM, White DA. Regulation of hamster hepatic microsomal triglyceride transfer protein mRNA levels by dietary fats. Biochem. Biophys. Res. Commun. 1995;212:473\u2013478. doi: 10.1006/bbrc.1995.1994.", "ArticleIdList": ["10.1006/bbrc.1995.1994", "7626061"]}, {"Citation": "Yuan X, et al. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PLoS ONE. 2009;4:e5609. doi: 10.1371/journal.pone.0005609.", "ArticleIdList": ["10.1371/journal.pone.0005609", "PMC2680617", "19440305"]}, {"Citation": "Hussain MM, Bakillah A. New approaches to target microsomal triglyceride transfer protein. Curr. Opin. Lipidol. 2008;19:572\u2013578. doi: 10.1097/MOL.0b013e328312707c.", "ArticleIdList": ["10.1097/MOL.0b013e328312707c", "PMC2650223", "18957879"]}, {"Citation": "Raederstorff DG, Schlachter MF, Elste V, Weber P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J. Nutr. Biochem. 2003;14:326\u2013332. doi: 10.1016/S0955-2863(03)00054-8.", "ArticleIdList": ["10.1016/S0955-2863(03)00054-8", "12873714"]}, {"Citation": "Kong L, Luo C, Li X, Zhou Y, He H. The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits. Lipids Health Dis. 2013;12:115. doi: 10.1186/1476-511X-12-115.", "ArticleIdList": ["10.1186/1476-511X-12-115", "PMC3735477", "23895132"]}, {"Citation": "Mariee AD, Abd-Allah GM, El-Beshbishy HA. Protective effect of dietary flavonoid quercetin against lipemic-oxidative hepatic injury in hypercholesterolemic rats. Pharm. Biol. 2012;50:1019\u20131025. doi: 10.3109/13880209.2012.655424.", "ArticleIdList": ["10.3109/13880209.2012.655424", "22775419"]}, {"Citation": "Vuong QV. Epidemiological evidence linking tea consumption to human health: a review. Crit. Rev. Food Sci. Nutr. 2014;54:523\u2013536. doi: 10.1080/10408398.2011.594184.", "ArticleIdList": ["10.1080/10408398.2011.594184", "24237002"]}, {"Citation": "Yuan C, et al. Dimethyl sulfoxide damages mitochondrial integrity and membrane potential in cultured astrocytes. PLoS ONE. 2014;9:e107447. doi: 10.1371/journal.pone.0107447.", "ArticleIdList": ["10.1371/journal.pone.0107447", "PMC4169574", "25238609"]}, {"Citation": "Wang JQ, et al. Preventive effects of total flavonoids of Litsea coreana leve on hepatic steatosis in rats fed with high fat diet. J. Ethnopharmacol. 2009;121:54\u201360. doi: 10.1016/j.jep.2008.09.029.", "ArticleIdList": ["10.1016/j.jep.2008.09.029", "18977425"]}, {"Citation": "Huang C, et al. Potential protective effects of a traditional Chinese herb, Litsea coreana Levl., on liver fibrosis in rats. J. Pharm. Pharmacol. 2010;62:223\u2013230. doi: 10.1211/jpp.62.02.0010.", "ArticleIdList": ["10.1211/jpp.62.02.0010", "20487202"]}, {"Citation": "Zhao X. Hawk tea (Litsea coreana Levl. var. lanuginose) attenuates CCl(4)-induced hepatic damage in Sprague\u2013Dawley rats. Exp. Ther. Med. 2013;5:555\u2013560. doi: 10.3892/etm.2012.840.", "ArticleIdList": ["10.3892/etm.2012.840", "PMC3570157", "23403509"]}, {"Citation": "Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 2016;7:27\u201331. doi: 10.4103/0976-0105.177703.", "ArticleIdList": ["10.4103/0976-0105.177703", "PMC4804402", "27057123"]}, {"Citation": "Tong X, Taylor AW, Giles L, Wittert GA, Shi Z. Tea consumption is inversely related to 5-year blood pressure change among adults in Jiangsu, China: a cross-sectional study. Nutr. J. 2014;13:98. doi: 10.1186/1475-2891-13-98.", "ArticleIdList": ["10.1186/1475-2891-13-98", "PMC4209085", "25311544"]}, {"Citation": "McDonald D, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012;6:610. doi: 10.1038/ismej.2011.139.", "ArticleIdList": ["10.1038/ismej.2011.139", "PMC3280142", "22134646"]}, {"Citation": "Reichenbach M, Reimann K, Reuter H. Gene expression in response to cyclic mechanical stretch in primary human dermal fibroblasts. Genom. Data. 2014;2:335\u2013339. doi: 10.1016/j.gdata.2014.09.010.", "ArticleIdList": ["10.1016/j.gdata.2014.09.010", "PMC4535970", "26484124"]}, {"Citation": "Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009;4:44. doi: 10.1038/nprot.2008.211.", "ArticleIdList": ["10.1038/nprot.2008.211", "19131956"]}, {"Citation": "Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat. Protoc. 2006;1:1559\u20131582. doi: 10.1038/nprot.2006.236.", "ArticleIdList": ["10.1038/nprot.2006.236", "17406449"]}, {"Citation": "Matysik S, Klunemann HH, Schmitz G. Gas chromatography-tandem mass spectrometry method for the simultaneous determination of oxysterols, plant sterols, and cholesterol precursors. Clin. Chem. 2012;58:1557\u20131564. doi: 10.1373/clinchem.2012.189605.", "ArticleIdList": ["10.1373/clinchem.2012.189605", "22997279"]}, {"Citation": "Zhao R, Xie Y, Tan Y, Tan C, Jiang Y. Binding of a bcl-2 family inhibitor to bovine serum albumin: fluorescence quenching and molecular docking study. Protein Pept. Lett. 2012;19:949\u2013954. doi: 10.2174/092986612802084401.", "ArticleIdList": ["10.2174/092986612802084401", "22486616"]}, {"Citation": "Huo, X. et al. A combination of pharmacophore modeling, molecular docking and virtual screening for NPC1L1 receptor inhibitors from Chinese herbs. Proceedings of the 8th International Conference on Systems Biology; 2014 Oct 24\u201327; Qingdao China, IEEE, New York. 40\u201343 (2014)."}, {"Citation": "Qiao L, et al. Discovery of anti-hypertensive oligopeptides from adlay based on in silico proteolysis and virtual screening. Int. J. Mol. Sci. 2016;17:e2099. doi: 10.3390/ijms17122099.", "ArticleIdList": ["10.3390/ijms17122099", "PMC5187899", "27983650"]}]}], "History": [{"Year": "2018", "Month": "8", "Day": "27"}, {"Year": "2019", "Month": "3", "Day": "21"}, {"Year": "2019", "Month": "5", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "5", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "5", "Day": "18", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "5", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["31098406", "PMC6506518", "10.1038/s42003-019-0396-4", "396"]}}]}